These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 8517382)

  • 1. Early decrease in minimal luminal diameter after successful percutaneous transluminal coronary angioplasty predicts late restenosis.
    Rodriguez A; Santaera O; Larribeau M; Sosa MI; Palacios IF
    Am J Cardiol; 1993 Jun; 71(16):1391-5. PubMed ID: 8517382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiologic response to gain and loss in coronary minimal luminal diameter in patients treated with coronary angioplasty: prediction of restenosis on the basis of exercise capacity.
    Jørgensen B; Simonsen S; Endresen K; Forfang K; Egeland T; Thaulow E
    Am Heart J; 2000 Mar; 139(3):482-90. PubMed ID: 10689263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of cilostazol on restenosis after percutaneous coronary balloon angioplasty.
    Tsuchikane E; Fukuhara A; Kobayashi T; Kirino M; Yamasaki K; Kobayashi T; Izumi M; Otsuji S; Tateyama H; Sakurai M; Awata N
    Circulation; 1999 Jul; 100(1):21-6. PubMed ID: 10393676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months.
    Serruys PW; Luijten HE; Beatt KJ; Geuskens R; de Feyter PJ; van den Brand M; Reiber JH; ten Katen HJ; van Es GA; Hugenholtz PG
    Circulation; 1988 Feb; 77(2):361-71. PubMed ID: 2962786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphologic changes during follow-up after successful percutaneous transluminal coronary balloon angioplasty: quantitative angiographic analysis in 778 lesions--further evidence for the restenosis paradox. MERCATOR Study Group (Multicenter European Research trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis).
    Hermans WR; Foley DP; Rensing BJ; Serruys PW
    Am Heart J; 1994 Mar; 127(3):483-94. PubMed ID: 8122593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Directional coronary atherectomy versus coronary angioplasty in vessels larger than 3 mm in diameter.
    Seyithanoglu BY; Zaki Masud AR; Ergene O; Morris WM; Kozan O; Corbelli JC; Wilson MF
    Jpn Heart J; 1998 Jan; 39(1):55-65. PubMed ID: 9601482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient, lesion, and procedural variables as risk factors for luminal re-narrowing after successful coronary angioplasty: a quantitative analysis in 653 patients with 778 lesions. Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.
    Hermans WR; Rensing BJ; Foley DP; Tijssen JG; Rutsch W; Emanuelsson H; Danchin N; Wijns W; Chappuis F; Serruys PW
    J Cardiovasc Pharmacol; 1993; 22 Suppl 4():S45-57. PubMed ID: 7523772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early alteration of coronary hemodynamics in late restenosis after coronary angioplasty.
    Wu TC; Chen JW; Chen CI; Mar GY; Hsu NW; Chen YH; Ding YA; Wang SP; Chang MS
    Jpn Heart J; 1999 Sep; 40(5):535-48. PubMed ID: 10888374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of coronary vessel size on renarrowing process and late angiographic outcome after successful balloon angioplasty.
    Foley DP; Melkert R; Serruys PW
    Circulation; 1994 Sep; 90(3):1239-51. PubMed ID: 8087933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prior restenosis predicts restenosis after coronary angioplasty of a new significant narrowing.
    Bresee SJ; Jacobs AK; Garber GR; Ruocco NA; Mills RM; Bergelson BA; Ryan TJ; Faxon DP
    Am J Cardiol; 1991 Nov; 68(11):1158-62. PubMed ID: 1951074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary stenting decreases restenosis in lesions with early loss in luminal diameter 24 hours after successful PTCA.
    Rodriguez AE; Santaera O; Larribau M; Fernandez M; Sarmiento R; Perez Baliño ; Newell JB; Roubin GS; Palacios IF
    Circulation; 1995 Mar; 91(5):1397-402. PubMed ID: 7867179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restenosis after coronary angioplasty for rapidly progressive coronary stenosis.
    Bauters C; Passart F; Lablanche JM; McFadden EP; Hamon M; Bertrand ME
    Eur Heart J; 1996 Nov; 17(11):1671-7. PubMed ID: 8922915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of restenosis after coronary balloon angioplasty: rationale and design of the Fluvastatin Angioplasty Restenosis (FLARE) Trial. The FLARE Study Group.
    Foley DP; Bonnier H; Jackson G; Macaya C; Shepherd J; Vrolix M; Serruys PW
    Am J Cardiol; 1994 May; 73(14):50D-61D. PubMed ID: 8198025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors, time course and treatment effect for restenosis after successful percutaneous transluminal coronary angioplasty of chronic total occlusion.
    Ellis SG; Shaw RE; Gershony G; Thomas R; Roubin GS; Douglas JS; Topol EJ; Startzer SH; Myler RK; King SB
    Am J Cardiol; 1989 Apr; 63(13):897-901. PubMed ID: 2522727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation between the deletion polymorphism of the angiotensin-converting enzyme gene and late luminal narrowing after coronary angioplasty.
    Hamon M; Bauters C; Amant C; McFadden EP; Helbecque N; Lablanche JM; Bertrand ME; Amouyel P
    Circulation; 1995 Aug; 92(3):296-9. PubMed ID: 7634441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary vasomotion after percutaneous transluminal coronary angioplasty depends on the severity of the culprit lesion.
    Mandinov L; Kaufmann P; Staub D; Buckingham TA; Amann FW; Hess OM
    J Am Coll Cardiol; 1997 Sep; 30(3):682-8. PubMed ID: 9283526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term luminal renarrowing after successful elective coronary angioplasty of total occlusions. A quantitative angiographic analysis.
    Violaris AG; Melkert R; Serruys PW
    Circulation; 1995 Apr; 91(8):2140-50. PubMed ID: 7697842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of stenosis morphology in the estimation of restenosis risk after elective percutaneous transluminal coronary angioplasty.
    Ellis SG; Roubin GS; King SB; Douglas JS; Cox WR
    Am J Cardiol; 1989 Jan; 63(1):30-4. PubMed ID: 2521196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulocyte activation in restenosis after percutaneous transluminal coronary angioplasty.
    Tsutsui M; Shimokawa H; Tanaka S; Yoshihara S; Higuchi S; Matsuguchi T; Okamatsu S
    Jpn Circ J; 1996 Jan; 60(1):27-34. PubMed ID: 8648881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiographic morphology of restenosis after percutaneous transluminal coronary angioplasty.
    MacDonald RG; Barbieri E; Feldman RL; Pepine CJ
    Am J Cardiol; 1987 Jul; 60(1):50-4. PubMed ID: 2955692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.